Light Sciences Oncology - Top 20 VC deals of 2008

Light Sciences Oncology, FierceBiotech top venture capital deals of 2008Company: Light Sciences Oncology
Based: Bellevue, WA
Amount: $41M

Investors: Novo, Essex Woodlands Health Ventures, Undisclosed Firm, Undisclosed Firm, Adams Street Partners, Undisclosed Firm

Scoop: Light Sciences Oncology, which is developing Light Infusion Therapy (Litx) to treat cancer and other conditions, closed its Series C round of financing in July. Researchers at the company are undertaking two Phase III clinical trials in patients with hepatocellular carcinoma and metastatic colorectal cancer. There's also a planned Phase III trial in glioblastoma multiforme, and early stage clinical trials in benign prostatic hyperplasia.

Light Sciences Oncology - Top 20 VC deals of 2008
Read more on

Suggested Articles

The drug failed a futility analysis in March, but Biogen resurrected it after factoring in data generated after the cutoff for the interim assessment.

The negative top-line data deal a big blow to the prospects of a drug analysts tipped to achieve blockbuster sales if it cleared phase 3.

Intrepida Bio launched with $9.5 million from Sofinnova and Canaan Partners to develop anti-BAG3 antibodies for the treatment of cancer.